NLM Logo

SM16 compound MeSH Supplementary Concept Data 2024


MeSH Supplementary
SM16 compound
Unique ID
C528106
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C528106
Entry Term(s)
4-(5-(benzo(d)(1,3)dioxol-5-yl)-4-(6-methylpyridin-2-yl)-1H-imidazol-2-yl)bicyclo(2.2.2)octane-1-carboxamide
Registry Number
0
Heading Mapped to
*Azabicyclo Compounds
Frequency
15
Note
an orally active TGF-beta type I receptor inhibitor prevents myofibroblast induction and vascular fibrosis in the rat carotid injury model; structure in first source
Source
Arterioscler Thromb Vasc Biol 2008 Apr;28(4):665-71
Date of Entry
2008/04/17
SM16 compound Preferred
4-(5-(benzo(d)(1,3)dioxol-5-yl)-4-(6-methylpyridin-2-yl)-1H-imidazol-2-yl)bicyclo(2.2.2)octane-1-carboxamide Broader
page delivered in 0.005s